RxDoctor Payments Data

Nathan Wass, DO

Family Medicine · Saugatuck, MINPI 1568725190

Payments from drug & device makers

$1,035in general payments, 2019–2025

Across 60 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$348
  • Pfizer$110
  • Amgen$99
  • AbbVie$77
  • Novartis$66
  • Antares Pharma, Inc.$57
  • plus $278 from 11 others

What the payments were for

  • Food & beverage$1,01698%
  • Education$192%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,035 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$14,615
Medicare patients
112
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban91$89,104
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$50,503
OzempicSemaglutide41$44,263
MounjaroTirzepatide40$44,082
JardianceEmpagliflozin32$41,472
XareltoRivaroxaban19$26,926
TrulicityDulaglutide14$23,351
JanuviaSitagliptin Phosphate16$22,667
FarxigaDapagliflozin Propanediol26$22,666
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$12,345
Incruse ElliptaUmeclidinium Bromide19$7,270
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$5,214
Atorvastatin Calcium309$4,701
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$4,052
Novolog FlexpenInsulin Aspart12$3,264

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$110$89,10491 claims
GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta$19$70,11995 claims
Lilly USA, LLCMounjaro, Trulicity$16$67,43254 claims
Novo NordiskOzempic$348$44,26341 claims
Boehringer IngelheimJardiance$51$41,47232 claims
Johnson & JohnsonXarelto$26$26,92619 claims
MerckJanuvia$42$22,66716 claims
AstraZenecaFarxiga$31$22,66626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Saugatuck

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →